Science finally figured out how to make effective RSV vaccines. Will seniors care?
(By Helen Branswell for STAT) The world has waited decades for vaccines to protect older adults against RSV. One, made
Read morePart D/Prescription Drugs
How Medicare’s Aduhelm decision revived old questions about new drugs
(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read moreThis Panel Will Decide Whose Medicine to Make Affordable. Its Choice Will Be Tricky
(By Markian Hawryluk for KFF Health News) Catherine Reitzel’s multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies
Read moreCMS proposes rules to improve Medicaid drug price transparency
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing a set of rules for drug manufacturers, pharmaceutical benefit managers
Read moreA More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
(By Arthur Allen for KFF Health News) Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal
Read moreNew Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published May 18, 2023) The FDA’s accelerated approval of Aduhelm
Read more340B reporting mandate approved by House subcommittee, legislation moves forward
(By Ashleigh Hollowell for Becker’s hospital Review) Legislation proposing transparency and oversight of the 340B drug discount program was passed
Read morePBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the
Read moreEli Lilly says an experimental drug slows Alzheimer’s worsening
(Source -The Associated Press published May 4, 2023 by NPR) WASHINGTON — Eli Lilly and Co. said Wednesday its experimental
Read more26 state attorneys general urge Medicare to cover Alzheimer’s treatments
(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read more